Stockscreener 앱 받기
16.54
0.72%
-0.12
시간 외 거래:
16.54
전일 마감가:
$16.66
열려 있는:
$16.66
하루 거래량:
156.03K
Relative Volume:
1.06
시가총액:
$418.11M
수익:
$236.35M
순이익/손실:
$-39.65M
주가수익비율:
-9.7864
EPS:
-1.6901
순현금흐름:
$-17.98M
1주 성능:
-5.70%
1개월 성능:
-2.99%
6개월 성능:
-13.76%
1년 성능:
-34.23%
1일 변동 폭
$16.33
$17.25
1주일 범위
$16.33
$18.01
52주 변동 폭
$15.28
$26.40
Orthopediatrics Corp Stock (KIDS) Company Profile
명칭
Orthopediatrics Corp
전화
574-268-6379
주소
2850 FRONTIER DRIVE, WARSAW, IN
Compare KIDS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KIDS
Orthopediatrics Corp
|
16.54 | 421.14M | 236.35M | -39.65M | -17.98M | -1.6901 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Orthopediatrics Corp Stock (KIDS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2025-12-10 | 개시 | Canaccord Genuity | Buy |
| 2025-04-07 | 개시 | Lake Street | Buy |
| 2024-01-25 | 다운그레이드 | Truist | Buy → Hold |
| 2021-06-14 | 재확인 | Needham | Buy |
| 2020-04-02 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-06-19 | 개시 | Needham | Buy |
| 2019-02-20 | 개시 | JMP Securities | Mkt Outperform |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
모두보기
Orthopediatrics Corp 주식(KIDS)의 최신 뉴스
OrthoPediatrics (NASDAQ:KIDS) CEO David Bailey Sells 19,535 Shares - MarketBeat
Insider Selling: OrthoPediatrics (NASDAQ:KIDS) General Counsel Sells 8,614 Shares of Stock - MarketBeat
Gregory Odle Sells 8,433 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock - MarketBeat
Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Insider Sells 8,596 Shares of Stock - MarketBeat
Fred Hite Sells 12,993 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock - MarketBeat
Orthopediatrics (KIDS) executive reports stock grant and tax-related sale - Stock Titan
OrthoPediatrics (KIDS) COO/CFO granted shares, sells stock for taxes - Stock Titan
OrthoPediatrics (KIDS) CEO share sale covers tax withholding on RSUs - Stock Titan
OrthoPediatrics (KIDS) president awarded shares, sells some for taxes - Stock Titan
OrthoPediatrics (KIDS) counsel gets 47,380-share grant, sells 8,614 - Stock Titan
[144] ORTHOPEDIATRICS CORP SEC Filing - Stock Titan
Granahan Investment Management LLC Has $14.08 Million Stock Position in OrthoPediatrics Corp. $KIDS - MarketBeat
Prosight Management LP Acquires 235,060 Shares of OrthoPediatrics Corp. $KIDS - MarketBeat
Orthopedic Prosthetics Market 2026 Improving Mobility With Advanced Biomechanical Design - Weekly Voice
OrthoPediatrics at Citizens Life Sciences: Pediatric Growth Strategy Unveiled - Investing.com
OrthoPediatrics Earnings Call Flags Profitable Turn - The Globe and Mail
Market Wrap: Will OrthoPediatrics Corp benefit from green energy policies2025 EndofYear Setup & Real-Time Volume Spike Alerts - baoquankhu1.vn
Wall Street Zen Upgrades OrthoPediatrics (NASDAQ:KIDS) to Hold - MarketBeat
Bank Watch: Can OrthoPediatrics Corp expand into new marketsDollar Strength & Weekly Top Stock Performers List - baoquankhu1.vn
Risk Off: Will OrthoPediatrics Corp outperform during market ralliesTrade Analysis Summary & High Win Rate Trade Alerts - baoquankhu1.vn
Medicaid Policy Shifts Pose Significant Revenue and Margin Risks for OrthoPediatrics - TipRanks
Orthopediatrics 2025 10-K: Revenue $236.3M, EPS $(1.69) - TradingView
OrthoPediatrics (NASDAQ: KIDS) outlines 2025 growth, deals and market focus - Stock Titan
OrthoPediatrics Corp. (NASDAQ:KIDS) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Wall Street Analysts See a 32.67% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High? - Finviz
OrthoPediatrics (NASDAQ:KIDS) Price Target Raised to $20.00 - MarketBeat
Truist Adjusts Price Target on OrthoPediatrics to $20 From $19, Maintains Hold Rating - marketscreener.com
Beyond The Numbers: 5 Analysts Discuss OrthoPediatrics Stock - Benzinga
OrthoPediatrics (NASDAQ:KIDS) Stock Price Expected to Rise, BTIG Research Analyst Says - Defense World
OrthoPediatrics Corp. (NASDAQ:KIDS) Q4 2025 Earnings Call Transcript - Insider Monkey
OrthoPediatrics (KIDS) Q4 2025 Earnings Transcript - AOL.com
OrthoPediatrics to Participate in Upcoming Conferences - National Today
OrthoPediatrics 2025 Financial Results: Q4 Loss, Annual Revenue $236.3MNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
OrthoPediatrics (NASDAQ:KIDS) Given New $30.00 Price Target at Needham & Company LLC - MarketBeat
OrthoPediatrics (NASDAQ:KIDS) Given New $24.00 Price Target at BTIG Research - MarketBeat
OrthoPediatrics Corp. Q4 2025 Earnings Call Summary - Yahoo Finance
Needham raises OrthoPediatrics stock price target to $30 on growth - Investing.com Nigeria
Needham raises OrthoPediatrics stock price target to $30 on growth By Investing.com - Investing.com Canada
OrthoPediatrics revenue up 15% to USD 236.3M in FY 2025 - Medical Buyer
OrthoPediatrics (NASDAQ:KIDS) Issues Quarterly Earnings Results - MarketBeat
OrthoPediatrics Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Orthopediatrics misses EPS forecast in Q4 2025 By Investing.com - Investing.com South Africa
OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Earnings call transcript: Orthopediatrics misses EPS forecast in Q4 2025 - Investing.com India
OrthoPediatrics Highlights Growth Strategy in 2026 Investor Presentation - TipRanks
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
OrthoPediatrics Q4 Earnings Call Highlights - MarketBeat
OrthoPediatrics: Q4 Earnings Snapshot - marketscreener.com
OrthoPediatrics Seeks Acquisitions - marketscreener.com
OrthoPediatrics (NASDAQ: KIDS) details 2025 growth and 2026 outlook - Stock Titan
Orthopediatrics Corp (KIDS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):